Screening and Lead Identification — Emery Pharma

At Emery Pharma, we build each screening and lead identification engagement around context. The right plan depends on what has already been learned, what remains uncertain, which inputs are ready, and how the results will influence the next decision. Our team brings those factors together early so the work has a clear purpose, an agreed path, and deliverables matched to your program.

Our screening and lead identification capabilities

We approach screening and lead identification by defining success before the first activity starts. We use early scoping to build a sharper request, review the proposed approach, and agree what a decision-ready result will look like. The goal is to find and validate tractable starting points with evidence strong enough to guide investment. Our project plan explains how the work will produce evidence for which hits or candidates should advance, be redesigned, or stop, including what will happen if results fall outside expectations. Early alignment on inputs, assumptions, responsibilities, and review gates is often the difference between useful evidence and an expensive activity report. Give our team enough non-confidential context to challenge assumptions, identify dependencies, and recommend a realistic path. We are an Alameda, CA-based contract research organization supporting drug discovery across small molecules, biologics (monoclonal antibodies, ADCs, gene therapy), and botanical products. Their integrated services span analytical chemistry, microbiology, molecular biology, and regulatory support, helping clients navigate from early discovery through IND-enabling studies. This context helps establish potential fit. Final selection should depend on project-specific evidence: the proposed scientific lead, relevant examples, methods, capacity, quality status, and timeline. Share the program context, available evidence, constraints, and the decision deadline. Resolve material gaps before the scope and quotation are finalized. Agree the methods, responsibilities, dependencies, controls, acceptance criteria, review points, and change process in one executable plan. Run the work against named milestones. This work sits within our Pre-Clinical Research capabilities and is coordinated with the wider program context when the scope requires it.

• Assay format, controls, library or modality, and throughput.

How we shape the scope

We use the kickoff process to turn a broad request into an executable project. Together, we confirm what is in scope, what is not, which inputs are critical, who owns each decision, and what completion looks like. We surface dependencies early and set a practical review cadence. If the evidence suggests that the original plan should change, we discuss the impact before expanding the work or committing additional resources.

Working with Emery Pharma

Collaboration is structured around useful decisions rather than routine status reporting. We share what has been completed, what the evidence currently indicates, which questions remain open, and where sponsor input is needed. Reviews can be adjusted to the pace and complexity of the project. This approach keeps the right people involved at the right time and reduces avoidable rework caused by late assumptions or unclear handoffs.

Deliverables built for the next decision

We build reporting requirements into the project plan instead of treating documentation as an afterthought. The team agrees on what must be captured, who will review it, and how revisions will be resolved. At completion, we organize the outputs around the project objective and provide enough context for qualified stakeholders to understand the work performed and the basis for the conclusions. Any proposed follow-on work is discussed separately, with a clear reason for why it may be useful.

Planning your screening and lead identification project with Emery Pharma

The best starting point for screening and lead identification is a concise brief covering the program question, current evidence, available inputs, constraints, expected outputs, and desired timeline. We use that brief to prepare a practical scope and identify any questions that should be resolved first. The proposal then gives both teams a shared basis for evaluating approach, effort, milestones, deliverables, and next steps.